Precision Monitoring for Individualized Medication: Clinical Value and Practice of a Five-Item Antiepileptic Drug LC-MS/MS Kit

Necessity of Therapeutic Drug Monitoring in Epilepsy Management

Epilepsy, as a chronic neurological disorder, often requires long-term administration of antiepileptic drugs to control seizures. Due to significant interpatient pharmacokinetic variability, blood drug concentrations at the same dose may differ several-fold, leading to poor efficacy or pronounced side effects in some patients. Therapeutic drug monitoring provides an objective basis for clinical dose adjustment by measuring steady-state blood drug concentrations, and is particularly applicable to broad-spectrum drugs such as phenytoin, carbamazepine, valproic acid, phenobarbital, and lamotrigine. The introduction of the five antiepileptic drug concentration assay kit (liquid chromatography-tandem mass spectrometry) enables simultaneous determination of five drug concentrations in a single analysis, significantly improving monitoring efficiency.

Technical Advantages of Liquid Chromatography-Tandem Mass Spectrometry

Traditional immunoassays are limited by cross-reactivity and interfering substances, often producing false positives or biased results. Liquid chromatography-tandem mass spectrometry, based on the dual dimensions of chromatographic separation and mass detection, offers high specificity and high sensitivity. This kit employs solid-phase extraction or protein precipitation for sample preparation, combined with an optimized chromatographic gradient and multiple reaction monitoring mode, enabling quantitative analysis of five drugs within minutes. Generally, the lower limit of quantification is required to be below 1/10 of the lower limit of the clinical reference range, ensuring accurate measurement of low-concentration samples. In addition, this method can effectively distinguish parent drugs from metabolites, avoiding concentration misjudgment caused by metabolite cross-reactivity.

Clinical Advantages of Simultaneous Determination of Five Drugs

In clinical practice, multidrug combination therapy is relatively common in refractory epilepsy. Traditional methods require separate detection of each drug, which is time-consuming and requires a large sample volume. The five antiepileptic drug concentration assay kit (liquid chromatography-tandem mass spectrometry) requires only a single sample to obtain a report of five drug concentrations, shortening report turnaround time and facilitating rapid assessment by physicians of medication adherence, dose appropriateness, and potential drug interactions. For example, when phenytoin is used in combination with valproic acid, the former can induce the metabolism of the latter, and monitoring results help to adjust the regimen promptly. At the same time, it reduces the number of blood draws for patients and improves the medical experience.

Precautions in Clinical Application

Despite excellent methodological performance, attention should still be paid in actual practice to sample collection time (usually trough concentration), anticoagulant selection (heparin or EDTA is acceptable, but requires validation), and sample stability. Method validation should be completed before use of the kit, including evaluation of precision, accuracy, extraction recovery, and matrix effects. Interpretation of results should be combined with individual factors such as patient age, liver and kidney function, and albumin levels, avoiding direct judgment based solely on concentration values. In addition, laboratories should regularly participate in external quality assessment to ensure comparability of results.